1. Home
  2. INOD vs CAPR Comparison

INOD vs CAPR Comparison

Compare INOD & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$90.50

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$29.82

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INOD
CAPR
Founded
1988
2005
Country
United States
United States
Employees
3000
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
INOD
CAPR
Price
$90.50
$29.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$100.00
$44.63
AVG Volume (30 Days)
2.4M
988.7K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3.37
N/A
EPS
0.42
N/A
Revenue
$86,775,000.00
N/A
Revenue This Year
$38.42
N/A
Revenue Next Year
$27.03
$3.31
P/E Ratio
$212.98
N/A
Revenue Growth
9.84
N/A
52 Week Low
$33.79
$4.30
52 Week High
$114.77
$40.37

Technical Indicators

Market Signals
Indicator
INOD
CAPR
Relative Strength Index (RSI) 74.76 41.93
Support Level $39.15 $26.06
Resistance Level $93.82 $30.06
Average True Range (ATR) 8.35 2.09
MACD 5.53 -0.55
Stochastic Oscillator 68.68 19.05

Price Performance

Historical Comparison
INOD
CAPR

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: